首页> 外文会议>Pharmaceutical Polymers New International Conference >FORMULATION AND CHARACTERISATION OF HOT MELT EXTRUDED DOSAGE FORMS: CHALLENGES AND OPPORTUNITIES
【24h】

FORMULATION AND CHARACTERISATION OF HOT MELT EXTRUDED DOSAGE FORMS: CHALLENGES AND OPPORTUNITIES

机译:热熔挤出剂型的配方和表征:挑战和机遇

获取原文

摘要

Hot-nielt extrusion (HME) is currently applied in the pharmaceutical field for manufacturing a variety of dosage forms and formulations such as granules, pellets, tablets, implants, transdermal systems, and ophthalmic inserts 1. The HME process has been evaluated to improve the dissolution rate of poorly water-soluble drugs by forming solid dispersions and solid solutions, to control or modify the drug release and to mask the bitter taste of the drug 2. For pharmaceutical applications, HME offers many advantages over traditional processing techniques, such as; (a) It is a solvent free processing method for solid dispersions and thus it is environment friendly and cost effective, (b) It offers the possibility of continuous processing and thus an efficient scale up from small scale laboratory extruder to large scale production size melt extruder. Increasing the dissolution rate of poorly water-soluble drugs is one of the major challenges in dosage form development. One approach is the formation of a solid dispersion of drug with a hydrophilic excipient. The ideal type of solid dispersion for increasing dissolution is a glass solution, in which the amorphous drug has a lower thermodynamic barrier to dissolution together with a maximally reduced particle size. In addition, the intimate presence of a hydrophilic excipient can increase wetting and lead to super-saturation in the diffusion layer. A glass solution is formed when two or more components are entirely miscible in the molten state and cool to form an amorphous one-phase system. However, to form a glass solution that is physically stable over prolonged periods of time the glass transition temperature (Tg) should be higher than the storage temperature (at least 50 °C above the storage temperature). This study focuses on the characterization of physico-chemical properties of a poorly water model drug and a hydrophilic model polymer to assess its suitability to manufacture solid dispersion/solution by hot melt extrusion process in order to increase the solubility of drug in the aqueous medium and consequently improving its oral bioavailability.
机译:目前在制造各种用量形式的药物领域和制剂如颗粒,颗粒,片剂,植入物,透皮系统和眼科插入物1. HME过程已经评估为改善通过形成固体分散体和固体溶液的溶解速率,通过形成固体分散体和固体溶液,控制或改变药物释放并掩盖药物的苦味2.对于药物应用,HME提供了与传统加工技术相比的许多优点,如; (a)是一种用于固体分散体的溶剂加工方法,因此它是环保且成本效益,(b)提供连续加工的可能性,从而从小规模实验室挤出机到大规模生产尺寸熔化的有效规模。挤出机。增加水溶性药物差的溶出速率是剂型发展中的主要挑战之一。一种方法是使用亲水赋形剂形成药物的固体分散体。用于增加溶解的理想类型的固体分散体是玻璃溶液,其中非晶药物具有较低的热力学阻挡层,以使粒径最大化地溶解。另外,亲水性赋形剂的静电存在可以增加润湿并导致扩散层中的超饱和度。当两个或更多个组分在熔融状态下完全混溶时形成玻璃溶液并冷却以形成无定形单相体系。然而,为了形成玻璃化转变温度(Tg)的玻璃化转变温度(Tg)的玻璃溶液应高于储存温度(储存温度高至少50℃)。本研究侧重于水模型药物和亲水模型聚合物的物理化学性质的表征,以评估其通过热熔挤出工艺制造固体分散/溶液的适用性,以增加药物在水性介质中的溶解度和因此提高了其口腔生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号